AARTI DRUGS
Back to Income Statement
|
AARTI DRUGS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹166 Cr | ₹205 Cr | ₹280 Cr | ₹141 Cr | ₹90 Cr |
What is the latest Consolidated Net Profit of AARTI DRUGS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹166 Cr |
Mar2023 | ₹205 Cr |
Mar2022 | ₹280 Cr |
Mar2021 | ₹141 Cr |
Mar2020 | ₹90 Cr |
How is Consolidated Net Profit of AARTI DRUGS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹166 Cr | -18.89 | |
Mar2023 | ₹205 Cr | -26.88 | |
Mar2022 | ₹280 Cr | 98.31 | |
Mar2021 | ₹141 Cr | 57.55 | |
Mar2020 | ₹90 Cr | - |
Compare Consolidated Net Profit of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹4,919.7 Cr | 0.7% | 17.6% | 0.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,466.0 Cr | 1.7% | 2% | -0.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,298.0 Cr | 0.4% | -2% | 37.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹127,538.0 Cr | 6% | 10.5% | 13.6% | Stock Analytics | |
CIPLA | ₹127,140.0 Cr | 6.8% | 4.6% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,500.0 Cr | 4.2% | 1.3% | -6.7% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | 0.7% |
17.6% |
0.2% |
SENSEX | -1% |
-3.2% |
1.6% |
You may also like the below Video Courses